Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Imagyn seeking to enjoin ABBI manufacturing and sales in Oct. 16 suit against USSC.

This article was originally published in The Gray Sheet

Executive Summary

IMAGYN SEEKS TO ENJOIN USSC MANUFACTURING AND U.S. SALES OF ABBI minimally invasive breast biopsy device in a suit filed Oct. 16 in Alexandria, Virginia Federal Court. Imagyn Medical Technologies, formally Urohealth Systems, claims that U.S. Surgical Corp.'s ABBI device infringes two patents held by Imagyn related to its Siteselect percutaneous excissional breast biopsy (PEBB) system. Imagyn submitted a 510(k) for Siteselect on June 20; the firm expects to launch the device in February 1998.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008973

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel